VP, Global Head of Medical Imaging, ICON
Program Manager, Clinical Operations
ICON
Project Manager, Pathology
ICON Central Laboratories
Digital Solutions to Alleviate NASH Clinical Trial Challenges
Broadcast Date: January 18, 2022
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
The prevalence of NASH in global populations continues to expand in conjunction with the ongoing obesity and diabetes epidemic. Over the next decade, the disease is projected to become the leading indication for a liver transplant. With no current approved drug treatment interest from the pharmaceutical industry, efforts by regulatory authorities and investigators to facilitate the development of new therapies that decrease the severity of NASH remain very strong, despite the high rates of attrition seen within pipelines to date.
This Inside Precision Medicine webinar will focus on the ability of digital technologies, including magnetic resonance imaging (MRI), magnetic resonance elastography (MRE), and whole slide imaging (WSI), to address some of these challenges. It will illustrate the ability of MRI and MRE to provide timely, high-quality, non-invasive solutions to enrolment and on the power of WSI to facilitate rapid complex workflows that assure consistent, high-quality assessments of primary efficacy endpoints by enabling expert histopathologists to interact remotely and in real-time.
A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.
Produced with support from:
